Methods for treating temporal lobe epilepsy, associated neurological disorders, and other patient functions

• US 20070055320A1
• Filed: 09/07/2006
• Published: 03/08/2007
• Est. Priority Date: 09/07/2005
• Status: Abandoned Application

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Northstar Neuroscience, Inc.
• Inventors: Weinand, Martin
• Application Number:
  US11/518,139
• Publication Number:
  US 20070055320A1
• Time in Patent Office: Days
• US Class Current: 607/45
• CPC Class Codes: A61N 1/0531 Brain cortex electrodes
• CPC Class Codes: A61N 1/36064 Epilepsy
• CPC Class Codes: A61N 1/36096 Mood disorders, e.g. depression, anxiety or panic disorder
• CPC Class Codes: A61N 1/36157 Current A61N1/3616 takes precedence
• CPC Class Codes: A61N 1/36171 Frequency

Abstract

Methods for treating temporal lobe epilepsy, associated neurological disorders, and other patient functions are disclosed. Methods for treating patients in accordance with several embodiments include implanting a signal delivery device subdurally proximate to a target neural site at a cortical location of a patient. The method can further include applying electrical signals to the target neural site via the signal delivery device, on a generally continual basis at a frequency of from about 0.9 Hz to about 250 Hz. The electrical signals can be applied to epileptic patients to at least reduce ictal and interictal epileptic senicity, and/or to patients functioning at normal or better levels to improve patient functioning.

Claims

1. A method for treating a patient, comprising:

identifying a target neural site at a parahippocampal gyrus of a patient;

implanting an electrode at a subdural location at least proximate to the target neural site; and

at least reducing both ictal and interictal epileptogenicity of the patient, including interictal neural dysfunction associated with epileptogenicity, by applying electrical signals to the target neural site via the electrode on a generally continual basis both ictally and interictally at a frequency of from about 0.9 Hz to about 250 Hz.

2. The method of claim 1 wherein applying electrical signals includes applying electrical signals at a current in the range of from about 0.1 mA to about 10 mA, and a pulse width in the range of from about 0.025 ms to about 0.5 ms.

3. The method of claim 1 wherein at least reducing interictal neural dysfunction associated with epileptogenicity includes at least reducing effects of a neuropsychological or neuropsychiatric disorder.

4. The method of claim 3 wherein at least reducing interictal neural dysfunction associated with epileptogenicity includes at least reducing effects of interictal behavior syndrome disorder.

5. The method of claim 3 wherein at least reducing effects of a neuropsychological or neuropsychiatric disorder includes at least reducing the effects of depression, an obsessive-compulsive disorder, rage attacks, an anxiety disorder, a disassociative disorder, or an experiential disorder.

6. The method of claim 3 wherein at least reducing effects of a neuropsychological or neuropsychiatric disorder includes at least reducing the effects of psychosis, delusional disorders, mania, personality disorders, or Geschwind syndrome.

7. The method of claim 1 wherein at least reducing interictal neural dysfunction associated with epileptogenicity includes at least reducing effects on at least one of the patient'"'"'s memory, learning, behavior, mood and senses.

8. The method of claim 1 wherein the electrical signals are first electrical signals, and wherein the method further comprises providing second electrical signals in direct response to epileptic seizure activity.

9. A method for treating a patient, comprising:

implanting an electrical signal delivery device proximate to a target neural site located at a temporal lobe of a patient; and

at least reducing non-epileptogenic symptoms of the patient by applying electrical signals to the target neural site via the electrical signal delivery device on a generally continual basis at a frequency of from about 0.9 Hz to about 250 Hz.

10. The method of claim 9 wherein at least reducing non-epileptogenic symptoms of the patient includes at least reducing symptoms associated with a stroke.

11. The method of claim 9 wherein at least reducing non-epileptogenic symptoms of the patient includes at least reducing symptoms associated with tinnitus.

12. The method of claim 9 wherein at least reducing non-epileptogenic symptoms includes at least reducing effects of a neuropsychological or neuropsychiatric disorder.

13. The method of claim 12 wherein at least reducing effects of a neuropsychological or neuropsychiatric disorder include at least reducing the effects of depression, an obsessive-compulsive disorder, rage attacks, an anxiety disorder, a disassociative disorder, or an experiential disorder.

14. The method of claim 12 wherein at least reducing effects of a neuropsychological or neuropsychiatric disorder include at least reducing the effects of psychosis, delusional disorders, mania, personality disorders, or Geschwind syndrome.

15. The method of claim 9 wherein at least reducing non-epileptogenic symptoms includes at least reducing effects on at least one of the patient'"'"'s memory, learning, behavior, mood and senses.

16. A method for treating a patient, comprising:

implanting an electrical signal delivery device subdurally proximate to a target neural site at a cortical location of a patient; and

improving a non-epileptogenic neurological characteristic of the patient by applying electrical signals to the target neural site via the electrical signal delivery device on a generally continual basis at a frequency of from about 0.9 Hz to about 250 Hz.

17. The method of claim 16 wherein applying electrical signals includes applying electrical signals at a frequency of from about 0.9 Hz to about 130 Hz.

18. The method of claim 16 wherein applying electrical signals includes applying electrical signals at a frequency of from about 50 Hz to about 100 Hz.

19. The method of claim 16, further comprising identifying the target neural site via a functional imaging technique.

20. The method of claim 16 wherein implanting an electrical signal delivery device includes implanting an electrical signal delivery device having multiple electrical contacts, and wherein the method further comprises:

receiving a feedback signal from the patient indicative of neural activity;

identifying a target contact located at least proximate to the neural activity; and

wherein applying electrical signals includes applying electrical signals to the target contact.

21. The method of claim 16 wherein receiving a feedback signal includes receiving a feedback signal from an implanted device.

22. The method of claim 16 wherein improving a neurological characteristic of a patient includes improving a neurological characteristic of a normally-functioning patient.

23. The method of claim 16 wherein improving a neurological characteristic of the patient includes improving a neurological characteristic that is at normal or better levels.

24. The method of claim 23 wherein improving a neurological characteristic of the patient includes improving a memory function of the patient.

25. The method of claim 23 wherein improving a neurological characteristic of the patient includes improving a neuropsychological function of the patient.

26. The method of claim 16 wherein implanting the electrical signal delivery device includes implanting an electrode at a subdural location.

27. The method of claim 16 wherein applying electrical signals includes enhancing neural cell metabolism.

28. The method of claim 16 wherein applying electrical signals includes applying electrical signals continuously over a period of several months.

29. The method of claim 16 wherein applying electrical signals includes applying electrical signals continuously over a period of several years.

30. The method of claim 16 wherein applying electrical signals includes applying electromagnetic signals at a subthreshold level.

31. The method of claim 16 wherein applying electrical signals includes applying electrical signals to increase cerebral blood flow to the target neural site.

32. The method of claim 16 wherein implanting the electrical signal device includes implanting a strip-shaped support member having multiple electrical contacts positioned within the patient'"'"'s skull.

33. The method of claim 16 wherein implanting an electrical signal device includes implanting an electrical signal device at a temporal lobe of the patient.

34. The method of claim 16, further comprising directing the patient to engage in an adjunctive behavior as part of a treatment regimen that includes both the adjunctive behavior and the application of electrical signals.

35. The method of claim 34 wherein directing the patient to engage in an adjunctive behavior includes directing the patient to engage in an adjunctive behavior simultaneously with applying the electrical signals.

36. The method of claim 34 wherein directing the patient to engage in an adjunctive behavior includes directing the patient to engage in at least one of a language task, a memory task, a musical task and a mathematical task.

37. A method for treating a patient, comprising:

identifying a target cortical neural site associated with a function that a patient performs at normal or better levels;

implanting an electrical signal delivery device at a subdural location proximate to the target cortical neural site;

improving the function of the patient by applying electrical signals to the target neural site via the electrical signal delivery device on a generally continual basis at a frequency of from about 0.9 Hz to about 250 Hz;

receiving automated feedback from the patient corresponding to the function; and

changing a location at which the signals are provided, based at least in part on the automated feedback.

38. The method of claim 37 wherein the electrical signal delivery device includes multiple electrical contacts and wherein changing a location at which the signals are provided includes changing a contact to which the signals are directed.

39. The method of claim 37 wherein improving a function includes improving a memory function.

40. The method of claim 37 wherein improving a function includes improving a learning function.

41. The method of claim 37 wherein receiving automated feedback includes receiving feedback from a feedback device implanted in the patient.

42. The method of claim 37, further comprising directing the patient to engage in an adjunctive behavior that includes a task directly associated with the function.

43. The method of claim 42 wherein directing the patient to engage in an adjunctive behavior includes directing the patient to engage in at least one of a language task, a memory task, a musical task and a mathematical task.